نتایج جستجو برای: نظریه منبع محور rbv

تعداد نتایج: 69073  

2014
Partha K. Chandra Feyza Gunduz Sidhartha Hazari Ramazan Kurt Rajesh Panigrahi Bret Poat David Bruce Ari J. Cohen Humberto E. Behorquez Ian Carmody George Loss Luis A. Balart Tong Wu Srikanta Dash Ranjit Ray

PURPOSE Chronic Hepatitis C Virus (HCV)-infected patients with liver cirrhosis (LC) respond poorly to interferon-alpha (IFN-α) and ribavirin (RBV) combination therapy, but the reason for this is unclear. We previously reported that HCV-infection induces endoplasmic reticulum (ER) stress and autophagy response that selectively down regulates the type I IFN-α receptor-1 (IFNAR1) and RBV transport...

2015
Chen-Hua Liu Chung-Feng Huang Chun-Jen Liu Chia-Yen Dai Jee-Fu Huang Jou-Wei Lin Cheng-Chao Liang Sheng-Shun Yang Chih-Lin Lin Tung-Hung Su Hung-Chih Yang Pei-Jer Chen Ding-Shinn Chen Wan-Long Chuang Jia-Horng Kao Ming-Lung Yu

The impact of ribavirin (RBV) dosage on sustained virologic response (SVR) rates remains elusive in hepatitis C virus genotype 2 (HCV-2) rapid responders receiving 16 weeks of peginterferon (Peg-IFN) plus RBV. Treatment-naïve HCV-2 patients with rapid virologic response (RVR) received Peg-IFN alfa-2a 180 μg/week plus weight-based RBV (1,000 or 1,200 mg/day; cut-off body weight: 75 kg) for 6 wee...

2013
Yasuteru Kondo Takanobu Kato Osamu Kimura Tomoaki Iwata Masashi Ninomiya Eiji Kakazu Masahito Miura Takehiro Akahane Yutaka Miyazaki Tomoo Kobayashi Motoyasu Ishii Norihiro Kisara Kumiko Sasaki Haruo Nakayama Takehiko Igarashi Noriyuki Obara Yoshiyuki Ueno Tatsuki Morosawa Tooru Shimosegawa

OBJECTIVE 1,25(OH)2 vitamin D3 can affect immune cells. However, the mechanism responsible for the favorable effects of 1(OH) vitamin D3, which becomes 1,25(OH)2 vitamin D3 in the liver, is not clear. The aim of this study is to analyze the immunological response of 1(OH) vitamin D3 supplementation in CH-C patients. DESIGN Forty-two CH-C patients were treated with 1(OH) vitamin D3/Peg-IFNα/RB...

Journal: :Enfermedades infecciosas y microbiologia clinica 2013
Juan Macías Antonio Rivero Celia Cifuentes Angela Camacho Karin Neukam Antonio Rivero-Juárez José A Mira Julián Torre-Cisneros Jesús Gómez-Mateos Juan A Pineda

INTRODUCTION Pegylated interferon plus ribavirin (Peg-IFN/RBV) therapy leads to improvements in liver stiffness measurements (LSM) in hepatitis C virus (HCV)-infected patients. However, the rate of LSM return to normal values in response to Peg-IFN/RBV is unclear. Thus, our aim was to assess the probability and factors associated with LSM normalization in HCV-infected patients receiving Peg-IFN...

2016
Zobair M. Younossi Maria Stepanova Linda Henry Fatema Nader Youssef Younossi Sharon Hunt

Patients' experience during treatment may affect treatment adherence. Our aim was to assess the impact of patient-reported outcomes (PROs) on adherence to different anti-hepatitis C virus (HCV) regimens.Clinical, demographic, and PRO data (short form-36 [SF-36], chronic liver disease questionnaire-hepatitis C version [CLDQ-HCV], functional assessment of chronic illness therapy-fatigue [FACIT-F]...

2013
Sara Ashtari Mohsen Vahedi Mohammad Amin Pourhoseingholi Mohammad Reza Zali

AIM The objective of this study was to evaluate the real outcomes of chronic hepatitis C patients, who treated with interferon plus ribavirin (INF-RBV) and peg-interferon plus ribavirin (PEG-RBV). BACKGROUND Despite the PEG-RBV has become a standard treatment of hepatitis C virus (HCV) around the world; and in Iran too, but in developing countries like as Iran, INF-RBV is still used among som...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003
Mark S Sulkowski

Hepatitis C virus (HCV) infection is a significant worldwide health care problem. Nearly one-third of all patients infected with human immunodeficiency virus (HIV) are coinfected with HCV. Compared with HIV-monoinfected persons, coinfected individuals experience more rapid progression of fibrosis and higher incidence of cirrhosis and death as a result of liver disease. Treatment for HCV infecti...

Journal: :Journal of animal science 2004
M R Smiricky-Tjardes I Mavromichalis D M Albin J E Wubben M Rademacher V M Gabert

A pig growth assay was conducted to determine the relative biological value (RBV) of lysine from L-lysine sulfate compared with feed-grade L-lysine HCl. One hundred nursery pigs with an average initial BW of 9.5 +/- 1.5 kg were blocked by BW and gender and allotted randomly to five dietary treatments in five replicates of four pigs per pen. A corn-peanut meal diet containing 0.6% total lysine (...

2002
M. R. Smiricky I. Mavromichalis D. M. Albin J. E. Wubben M. Rademacher V. M. Gabert

A pig growth assay was conducted to determine the relative biological value (RBV) of lysine from L-lysine sulfate relative to feed grade lysine·HCl. A maize-peanut meal diet containing 6.2 g/kg total lysine was supplemented with 2 levels (1 and 2 g/kg) of lysine from L-lysine·HCl or L-lysine sulfate. The RBV of L-lysine sulfate was determined using multiple regression slope-ratio methodology, w...

Journal: :PloS one 2015
Juan Macías Luis F López-Cortés Francisco Téllez Eva Recio Guillermo Ojeda-Burgos Maria José Ríos Antonio Rivero-Juárez Marcial Delgado Rivas-Jeremías Juan A Pineda

BACKGROUND Nitazoxanide (NTZ) plus pegylated interferon and ribavirin (Peg-IFN/RBV) improved the sustained virological response (SVR) achieved with Peg-IFN/RBV in hepatitis C virus genotype 4 (HCV-4)-monoinfected patients. There are no data currently on the efficacy of Peg-IFN/RBV plus NTZ for human immunodeficiency virus (HIV)/HCV-4 coinfection. Therefore, the objectives of this clinical trial...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید